flutamide has been researched along with Minimal Disease, Residual in 2 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The vast majority of residual tumors were poorly differentiated (Gleason score ≥ 8)." | 2.76 | Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial. ( Ahlgren, G; Angelsen, A; Bergh, A; Haugen, OA; Solberg, A; Tasdemir, I; Viset, T; Widmark, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Solberg, A | 1 |
| Haugen, OA | 1 |
| Viset, T | 1 |
| Bergh, A | 1 |
| Tasdemir, I | 1 |
| Ahlgren, G | 1 |
| Widmark, A | 1 |
| Angelsen, A | 1 |
| Köllermann, J | 1 |
| Feek, U | 1 |
| Müller, H | 1 |
| Kaulfuss, U | 1 |
| Oehler, U | 1 |
| Helpap, B | 1 |
| Köllermann, MW | 1 |
1 trial available for flutamide and Minimal Disease, Residual
| Article | Year |
|---|---|
Residual prostate cancer in patients treated with endocrine therapy with or without radical radiotherapy: a side study of the SPCG-7 randomized trial.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biopsy; Combined Modality The | 2011 |
1 other study available for flutamide and Minimal Disease, Residual
| Article | Year |
|---|---|
Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Flutamide; Humans; Leuprolide; Male | 2000 |